Sun Pharmaceuticals launches drug for advanced breast cancer patients

Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.

Breast cancer
Representative image
Press Trust of India Mumbai
1 min read Last Updated : Jan 11 2023 | 7:05 PM IST

Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.

The company said the generic drug will be available in 75, 100, 125 mgs.

Kirti Ganorkar, chief executive of Sun Pharma's domestic business, said the new drug will be priced at an affordable rate but did not disclose the same. Palenotm will address the treatment needs of several advanced breast cancer patients.

The company will also introduce a patient assistance programme that will improve patient compliance and accessibility, Ganorkar added.

Palbociclib, which is a generic medicine, is approved by the USFDA, EMA and CDSCO in combination with hormonal therapies for patients with hormone receptor positive, human epidermal growth factor receptor, negative locally advanced or metastatic breast cancers.

Breast cancer affects around 0.21 million women every year. Among the total patients, around 50 per cent are hormone receptor positive, the major subtype in breast cancer.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Sun Pharmabreast cancerPharmaceutical companies

First Published: Jan 11 2023 | 7:05 PM IST

Next Story